Home | Our experts

Our experts

A


Alfredo Addeo, MD Oncology Department, Geneva University Hospital, Geneva, Switzerland


Paolo A. Ascierto, MD Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Instituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Naples, Italy

B


Joaquim Bellmunt, MD Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Hospital del Mar Medical Research institute (IMIM), Barcelona, Spain


Anders Bjartell, MD Department of Urology, Skåne University Hospital, Malmö, Sweden


Hossein Borghaei, MD Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

C


Fatima Cardoso, MD Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal


Simon Chowdhury, MD Consultant Medical Oncologist, London, UK


Javier Cortes, MD Breast Cancer Research Program
Vall d’Hebron Institute of Oncology, Barcelona, Spain


Carmen Criscitiello, MD Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy


Giuseppe Curigliano, MD Division of Early Drug Development, European Institute of Oncology, Milan, Italy

D


Rebecca Dent, MD Division of Medical Oncology, National Cancer Center Singapore, Singapore


Véronique Diéras, MD Department of Medical Oncology, Centre Eugène Marquis, Rennes, France


Reinhard Dummer, MD Department of Dermatology, University of Zurich, Switzerland


Ignacio Duran, MD, PhD Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

E


Eleni Efstathiou, MD University of Texas MD Anderson Cancer Center, Houston, TX, USA


Hermann Einsele, MD Medizinische Klinik und Poliklinik II, ZIM, Universitätsklinikum Würzburg, Würzburg, Germany


Toby Eyre, MD Oxford University Hospitals NHS Trust, Oxford, UK

F


Peter A. Fasching, MD Department of Gynecology and Obstetrics Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany

G


Karen Gelmon, MD Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada


Alessandra Gennari, MD Department of Translational Medicine, University of Piemonte Orientale;
Division of Oncology, Maggiore della Carita Hospital, Novara, Italy


Nicolas Girard, MD Institut du Thorax Curie Montsouris, Institut Curie, Paris, France


Peter Goebell, MD Department of Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany


Frank Griesinger, MD Department of Hemtology and Oncology, Pius Hospital Oldenburg, Germany


Marc-Oliver Grimm, MD Department of Urology, University Hospital Jena, Germany


Petros Grivas, MD Division of Medical Oncology
University of Washington School of Medicine, Seattle, Washington, USA


Christian Grohé, MD Internal medicine, cardiology and pulmonology, Evangelical Lung Clinic, Johannesstift Diakonie, Berlin, Germany

H


Hans Hammers, MD Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medcial Center, Dallas, Texas, USA


Nadia Harbeck, MD Breast Center, Department of Obstetrics and Gynecology and CCCLMU, University of Munich, Germany


Axel Hauschild, MD Department of Dermatology, Venerology and Allergology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany


Matthew D. Hellmann, MD Memorial Sloan Kettering Cancer Center, New York, NY, USA


Lizza Hendriks, MD Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands

I


Philipp Ivanyi, MD Medizinische Hochschule Hannover, Germany

J


Mats Jerkeman, MD Department of Hematology, Lund University Hospital, Lund, Sweden


Stephen R D Johnston, MD The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK

L


Marco Ladetto, MD Hematology Division, Az Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy


C. Ola Landgren, MD PhD Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami Health System, Miami, FL, US


Brea Lipe, MD University of Rochester Medical Center, Rochester, NY, USA


Stephen Liu, MD Thoracic Mecial Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington D.C., USA


Georgina Long, MD Melanoma Institute Australia, The University of Sydney, Sydney, Australia;
Royal North Shore Hospital, St Leonards, NSW, Australia


Yohann Loriot, MD Department of Medical Oncology, Gustave Roussy, Villejuif, France


Diana Lüftner, MD Department of Hematology, Oncology and Tumor Immunology, Charité University Hospital, Campus Benjamin Franklin, Berlin, Germany

M


Ana Marín Niebla, MD, PhD Department of Hematology, Lymphoma Unit, University Hospital Vall d'Hebron, Barcelona, Spain


Axel S. Merseburger, MD Department of Urology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany


Maximilian Merz, MD Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany


Gil Morgan, MD Skåne University Hospital, Lund, Sweden


Denis Moro-Sibilot, MD Unité d’Oncologie Thoracique, Service Hospitalier Universitaire Pneumologie Physiologie Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France


Volkmar Müller, MD Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany


Declan Murphy, MD Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne,
Australia

N


Paul Nathan, MD Department of Medical Oncology, Mount Vernon Cancer Centre, London, UK


Andrea Necchi, MD Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

P


Sumanta (Monty) Kumar Pal, MD City of Hope National Medical Center, Duarte, CA, USA


Barbara Pistilli, MD Breast Cancer Group, Gustave Roussy, Villejuif, France


Michael Postow, MD Department of Medicine, Memorial Sloan Kettering Cancer Center New York, NY, USA


Tom Powles, MD Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK

R


Martin Reck, MD Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany


Noemi Reguart, MD Oncology Department, Hospital Clinic Barcelona, Spain


Sacha Rothschild, MD Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland


Hope Rugo, MD Department of Medicine (Hematology/Oncology), Breast Oncology and Clinical Trials Education, University of California San Francisco, CA, USA

S


Dirk Schadendorf, MD Department of Dermatology, University Hospital Essen, Germany


Fredrik Schjesvold, MD, PhD Oslo Myeloma Center at Oslo University Hospital, Oslo, Norway


Andreas Schneeweiss, MD Section gynecological oncology at the National Center for Tumor Diseases (Centrum für Tumorerkrankungen) (NCT) Heidelberg, Germany


Elzbieta Senkus-Konefka, MD Department of Oncology & Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland


Riyaz Shah, MD Maidstone and Tunbridge Wells NHS Trust, Kent, UK


Neal Shore, MD Carolina Urologic Research Center and Atlantic Urology Clinics, LLC, Myrtle Beach, South Carolina, USA


Pieter Sonneveld, MD Erasmus MC Cancer Institute, Rotterdam, Netherlands

T


Daniel Shao-Weng Tan, MD Division of Medical Oncology at National Cancer Centre Singapore; Duke-NUS Medical School, Singapore


Michael Thomas, MD Thorax Clinic Heidelberg, Heidelberg University Hospital, Heidelberg, Germany


Sara Tolaney, MD Dana-Farber Cancer Institute, Harvard Medcial Scool, Boston, MA, USA

U


Michael Untch, MD Department of Gynaecology and Obstetrics, Breast Cancer and Gynecologic Oncology Center, HELIOS Klinikum Berlin Buch, Germany

W


Katja Weisel, MD Medizinische Klinik und Poliklinik, Zentrum für Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany